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Summary.-The formation of lung colonies by i.v. injected Lewis lung-tumour
cells in syngeneic recipients was greatly enhanced by prior treatment of the mice
with cyclophosphamide. The lung-cloning efficiency was linearly related to cyclo-
phosphamide dose and the optimum time of treatment was 2-4 days before the
injection of tumour cells. The resulting lung colonies had a similar size distribution
to colonies in untreated recipients. Bleomycin, local thoracic irradiation and whole-
body irradiation were much less effective in enhancing the lung-cloning efficiency.
Cyclophosphamide also enhanced the take probability ofi.m. implanted tumour cells.
THE production of artificial lung meta-
stases by i.v. injected cells has been used
as a method of assaying the clonogenic
capacity of cells removed from treated
murine tumours. This approach was first
described by Hill and Bush (1969) using
the KHT sarcoma, and since that time it
has been applied to a number of other
mouse tumouirs including the C22LR
osteosarcoma (van Putten et al., 1975)
and the Lewis lung tumour and B16
melanoma (Hill and Stanley, 1975). A
high cloning efficiency in the lungs for i.v.
injected cells is important in reducing the
possibility that the colonies are formed by
a selected group of tumour cells and also
because the higher the cloning efficiency
the greater the sensitivity of the assay.
Brown (1973) showed that local thoracic
irradiation increased the lung-cloning
efficiency of the KHT sarcoma, and more
recently van Putten et al. (1975) have
shown that a variety of systemically
administered cytotoxic agents enhance
the lung-cloning efficiency of the C22LR
osteosarcoma.
The present work was designed to
confirm that drug-induced enhancement
of lung cloning also occurs with the
Lewis lung tumour, and to investigate in
44
particular the considerable enhancement
that is found using cyclophosphamide.
MATERIALS AND METHODS
The Lewis lung tumour was maintained by
serial i.m. passage in C57BL mice of the
Institute of Cancer Research colony. Cell
suspensions were prepared by chopping the
tissue finely with crossed scalpels, followed by
a two-stage trypsinisation. The digestion
medium contained 2-5% by volume of Bacto
trypsin (reconstituted as recommended by
Difco Laboratories) plus 50 ,ug/ml of DNAse
in phosphate-buffered saline (PBS). After a
preliminary 10 min incubation to remove
dead cells, the main incubation lasted 20 min.
Brief shaking of the tissue fragments in
fresh medium brought large numbers of cells
into suspension; the yield of cells that were
scored as viable under phase-contrast micro-
scopy was usually in the range 2 x 107 to
108 cells/g. Percentage cell viability was
usually in excess of 90//O.
I.v. injections of tumour cells were made
into the lateral tail veins of recipient mice,
under ether anaesthesia. Following Hill and
Bush (1969) and Hill and Stanley (1975)
every injection included 106 151Lm plastic
microspheres and 106 Lewis lung-tumour cells
that had been sterilized by treatment with
10 krad of 60Co y-rays (HR cells). The totalG. G. STEEL AND K. ADAMS
injection volume was 0u3 ml. Mice were
killed 15-18 days after i.v. implantation; the
lungs were removed and fixed in Bouin's
solution, and the colonies visible over the
whole lung surface were counted under a
dissecting microscope. When colony-size dis-
tributions wererequired, the colonydiameters
were measured by means of plastic calipers
gr duated to a precision of 0 1 mm.
Whole-body irradiation by 60Co y-rays was
given at a dose rate of 300 rad/min to a
dose of 700 rad. Thoracic irradiation by
X-rays was accomplished by anaesthetizing
the mice with sodium pentobarbitone (60 mg/
kg) and placing groups of 10 mice in a
circular array within a perspex chamber, the
top of which was covered with a 3 mm lead
sheet. The mice were located by round
perspex pegs on each side of the neck, and
1 cm expanded polystyrene blocks on either
side of the abdomen. Above each mouse a
trapezoidal hole was cut in the lead shield
(1-8 cm deep tapering from 2 3 to 1I3 cm) and
these were checked, by diagnostic X-ray
exposures, to be located precisely over the
thorax. During irradiation, the chamber was
kept warm on a heating plate, and air at
32°C was passed through the chamber at
approximately 2 1/min. The irradiations were
carried out at 230 kV, 15 mA with 1 mm Cu
and 1 mm Al filtration.
RESULTS
Three cytotoxic agents were investi-
gated for their ability to enhance lung
colony formation by the Lewis lung
tumour: cyclophosphamide (CY) (the
agent that in the hands of van Putten et
al. (1975) gave the greatest enhancement
with the C22LR osteosarcoma) local
thoracic or whole-body irradiation (found
by Brown (1973) to enhance colony
formation by the KHT sarcoma) and
bleomycin (because of its tendency to
enhance radiation-induced lung damage).
The experiments were designed to measure
the "enhancement factor" due to pre-
treatment of the recipient mice (i.e. the
ratio of lung-colony counts in treated and
control mice given the same cell suspen-
sion). All mice received 106 HR cells and
106 microspheres mixed with the required
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FIG. 1.-The enhancement factor for lung-
colony formation as a result of 4 different
types of pretreatment. Circles, 250 mg/
kg cyclophosphamide (CY) (the different
symbols indicating separate experiments);
Ol 50 mg/kg bleomycin; V local thoracic
irradiation to 200 rad; A 700 rad whole-
body irradiation.
dose of viable tumour cells, and each
experiment included untreated controls.
Treatment with CY was found greatly
to enhance the lung-cloning efficiency
(Fig. 1). Using a dose of 250 mg/kg,
given i.p. at up to 9 days before the
cells, the enhancement factor was always
greater than 5, and it showed abroadpeak
in the region of 2-4 days before cell
injection. The precise shape ofthis peak is
difficult to define because of inter-experi-
ment variations in lung-colony enhance-
ment. In our experience, lung-cloning
efficiency has sometimes varied by a
factor of 195-2 0 between separate groups
of mice in one experiment, and by more
than this between experiments (Hill and
Stanley, 1975). In spite of this variation,
the data shown in Fig. 1 indicate that
within the optimum range of intervals
(2-4 days) the lung-colony enhancement
factor was in the range 20-35. Even
when CY was given only 6 h before the
cells, a considerable level of enhancement
(10-15) was still observed.
Fig. 2 shows the dependence of lung-
cloning efficiency on the dose of CY,
administered 3 days before the cells. The
data indicate that the enhancement factor
increased linearly with dose. In one group
of mice given 250 mg/kg CY, the micro-
spheres were omitted in order to see
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Fic. 2. The lrng-cloning efficiency (ratio
of colonies per lung to the number of viable
tumour cells injected) as a function of the
dose of CY given 3 days before the cells.
A shows the effect of omitting microspheres
from the injection. Error bars show
i s.d.
whether the drug-induced enhancement of
lung cloning abolishes the need for
microspheres. The lung-cloning efficiency
was reduced to about one quarter of the
value with microspheres, suggesting that
these two types of enhancement are at
least partially independent.
Bleomycin was much less efficient in
enhancing lung-colony formation by the
Lewis lung tumour. As shown in Fig. 1, a
dose of 50 mg/kg produced a maximum
enhancement factor of3.5, whiehdepended
on the timing of the pretreatment in a
way that was consistent with the CY
results. A dose-response study for bleo-
mycin given 3 days before the cells also
showed a well defined linear dependence,
with an increase of one multiple of the
control cloning efficiency foreach 25 mg/kg
bleomvcin dose. Omitting microsplheres
greatly reduced the drug-induced enhance-
ment.
The 2 studies with radiation were
designed to test the lung-cloning enhance-
ment due to local thoracic irradiation
and whole-body irradiation. A dose of
2000 rad X-rays (Fig. 1) produced a rise
in lung-colony enhancement that peaked
at 2 days but which was not critically
dependent on timing. The maximum
enhancement factor was 4-8. 700 rad
whole-body irradiation gave a maximum
factor of 6 4, and the time-course of this
effect appeared to be different from that
seen with the other 3 treatments. The
peak was probably within the first day
after treatment.
The enhancement of lung-cloning effi-
ciency due to CY treatment has been
studied in more detail, as a technical
advantage in the use of the lung colony
assay, and perhaps with therapeutic
implications. Histological studies of the
lungs of non-tumour-bearing mice given
250 mg/kg of CY at various intervals
before they were killed, showed evidence of
acute pulmonary injury. Severe con-
gestion and focal oedema developedduring
the first 48 h and this was followed by hyperplasia of epithelial and interstitial
components, lasting until the 9th day.
Gould and Miller (1975) studied the
ultrastructure of rat lungs after CY injec-
tion and they described extensive damage
to the respiratory surface during the
first 48 h, with ensuing hyperplasia. By
3-4 weeks after CY, severe septal fibrosis
was seen. Although it is not possible to
identify histopathological features that
might be expected to lead to enhanced
lung-colony formation, it appears that
the peak of enhancement that we have
observed coincides with the period of
acute injury and the onset of repair
hyperplasia.
The effect of CY pretreatment on
colony size was studied by killing mice
15 days after the implantation of Lewis
lung-tumour cells, with and without pre-
treatment with 250 mg/kg CY at - 30 h.
The results are shown in Fig. 3 for the size
of 99 colonies in normal mice and 261
colonies in pretreated mice. The mean
colony diameters were 138 mm (s.e. 0-020)
in normal mice and 1 32 mm (s.e. 0-019)
in pretreated mice. This difference is not
significant, but in a similar study using
the B16 melanoma, 250 mg/kg CY
at 30 h gave an enhancement factor of
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Fia. 3. Distributions ofcolony size in normal
and pretreated recipients, normalised to a
sample of 100 colonies. The pretreated
animals received 250 mg/kg CY 30 h before
the cells. All the mice were killed 15
days after injection of tumour cells.
13 and there was a significant reduction in
colony size in the pretreated recipients.
We have previously shown (Steel and
Adams, 1975) that the Lewis lung tumour
shows a high transplantation efficiency for
i.m. implantation, and that the addition
of 106 lethally irradiated (HR) cells
reduced the TD50 (the number of
viable tumour cells required for *5000
take probability) from 600 to less t>ten 3
cells. It was interesting, therefore, to
investigate whether CY pretreatment also
improved the i.m. transplantability of
this tumour. Since the TD50 with 106 HR
cells added was close to the ultimate
ininimum value of 0 7 cells per implant,
we tested the effect of pretreatment in the
absence of added HR cells, and also with
a reduced number of HR cells (105 per
implant). The results are shown in Fig. 4.
Treatment 3 days beforeimplantationwith
250 mg/kg CY reduced the TD50 in the
absence of HR cells from 170 (confidence
limits 116-250) to 4a1 (confidence limits
2.8-6.0). The same treatment reduced the
TD50 in the presence of 105 HR cells from
52 (confidence limits 32-82) to 2-1 (confi-
dence limit 1'5-3.2). The CY pretreatment
was, therefore, much more effective than
this reduced dose of HR cells in achieving
a low TD50 for i.m. implantation. A
simultaneous study of the time taken for
FIG. 4.-The proportion of tumour takes as
a function of the number of viable tumour
cells implanted into the hind leg. Each
point (lenotes the scoring of 20 implants
(2/mouse). --- C2--- no HR cells added
(normal recipients); 0 105 HR
cells added (normal recipients); --- V---
no HR cells added (pretreated recipients);
A 105 HR cells added (pretreated
recipients). Pretreatment was 250 mg/kg
CY 3 (lays before the cells. The lines are
cumulative Poisson curves fitted to the
data by the method of Porter and Berry
(1963). The horizontal bars show the 95%
confidence limits on the TD50-
implants ofknown cell numbers to reach a
standard leg diameter of 10 mm showed
that pretreatment had no effect on the
early growth rate of tumour implants. All
the data in Fig. 4 are consistent with a
cumulative Poisson relation between take
probability and the inoculum size, indi-
cating that the improvement was not due
to pretreatment making the receptivity of
the implantation sites more uniform. It
appears t;o be due to a decrease in the num-
ber of implanted cells that was required
for the initiation of tumouir growth.
DISCUSSION
Drug-induced enhancement of lung
cloning is interesting from at least 3
points ofview: as a means ofimproving the
sensitivity of the lung-colony assay for
clonogenic cell survival; as a potential
risk in adjuvant chemotherapy; and, from
a fundamental standpoint, as a mechanism
in metastasis that needs to be understood.
Our interest in this phenomenon
stemmed primarily from the first point of
view. The lung-colony assay has proved
to be a valuable technique for the measure-
ment of clonogenic cell survival in the
Lewis lung tumour (Hill and Stanley,
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1975; Shipley et al., 1975; Steel and
Adams, 1975). Its sensitivity is governed
by the lung-cloning efficiency of untreated
tumour cells. In untreated recipients,
using 106 microspheres and 106 HR cells
to enhance lung cloning, , 200 viable
Lewis lung-tumour cells must be injected
for each lunig colony formed and since the
recipients can tolerate up to 106 viable
ttumour cells, the minimum surviving
fraction that can be detected is approxi-
mately 2 x 10-4. Pretreatment with CY
raised the lung-cloning efficiency in the
experiments described here to one colony
per 3-5 cells injected, improving the
seinsitivity of the assay by a factor of
about 50. This is a useful technical
advantage. AVe have made use of this
enhancement to study the survival of
Lewis lung-tumour cells to CY, MeCCNU
and adriamycin, aind the results have been
consistent with those obtained in non-
)retreated recipients. Our results confirm
the work of van Putten et al. (1975) in
identifying the strong lung-colonv en-
hancing )roperty of CY. They gave the
drug 2 days before the C22LR osteo-
sarcoma cells and observed an enhance-
ment factor of 158-1000. As shown in
Fig. 1, we have found that the enhance-
ment, of Lewis lung-cell cloning is broadly
time-dependent, although a useful gain
was observed for intervals from 6 h to 6
days before the cells. During the prepara-
tion of this report, Carmel and Brown
(1977) have published a description of
their experiments on the enhancement by
CY of luing cloning by the KHT sarcoma.
These investigators alsofoundconsiderable
enhancement of lung-colony formation,
whose time-relation was broadly consis-
tent with what we have found. Thev
examined the influence of anticoagulants
on ltung-colony formation, and concluded
from these experiments, and from the
effect of CY combined with whole-bodv
irradiationi, that neither specific immuno-
logical nor clotting factors were involved
in the CY effect.
Our resuLlts with local thoracic irradia-
tion compare well with the work of
Brown (1973) who found that 2000 rad to
the thorax increased the lung-cloning effi-
ciency of the KHIT sarcoma by a factor of
6. The time-course of his enhancement
seemed similar to that observed here with
whole-body irradiation (Fig. 1) but more
work would be required to consolidate
this finding. Withers and Milas (1973)
found that the lung-cloning efficiency of a
chemically induced C3H mouse fibro-
sarcoma was increased by a factor of 10
after 1000 rad thoracic irradiation, this
maximum value occurring 1 day after
irradiation. Bearing in mind that van
Putten et al. (1975) observed enhancement
factors of 6-12 following 1000 rad thoracic
irradiation, it wouild appear that, within 4
different mouse tumour systems, the
effect of irradiation is roughly the same.
There is a contrast, however, with the
work of van den Brenk and Kelly (1974)
who found that 1250 rad of thoracic
irradiation to rats increased the cloning
efficiency of the Walker tumour by a
factor of 200, with a peak at 21 days
after irradiation.
The clinical implications of these re-
sults are hard to evaluate. It is well-known
that cancer patients often have consider-
able numbers of tumour cells in the
blood, and the fact that the incidence of
circulating tumour cells bears little rela-
tionship to the incidence of metastases
has been taken to suggest that it is the
fixation of such cells rather than their
release which is important (Malmgren,
1968; Hoover and Ketcham, 1975). If so,
drug-induced enhancement of fixation
could have serious consequences. The
fact that enhancement of true metastasis
(as opposed to colony formation by i.v.
injected cells) can occur is clear from the
work of Cobb (1968) who found that
nitrogen mustard treatment increased
the incidence of lung metastases from
chemically induced rat fibrosarcomas, and
Dao and Yogo (1.967) who found enhance-
ment of the metastasis of mammary
tumours in rats, as a result of thoracic
irradiation. The data, therefore, encourage
vigilance in respect of the incidence of
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metastatic spread in patients treated with
cyclophosphamide and other agents as an
adjuvant to surgery.
The mechanisms that lead to a high or
low cloning efficiency in the lung for i.v.
injected tumour cells are not clear.
Brown (1973) found that radiation-
induced enhancement of lung cloning
was associated with a reduced clearance
rate of 1251-labelled cells from the lungs
during the first 2 days after implantation.
Essentially all the labelled cells were
trapped in the lungs within 5 min, but
within 12 h the irradiated lungs retained
significantly more radioactivity. This does
not necessarily indicate that pre-irradia-
tion delays the escape of viable cells from
the lung: the results may reflect a higher
survival ofviable cells within the irradiated
lungs. In this respect our results on i.m.
implantation (Fig. 4) are interesting.
Peters and Hewitt (1974) have suggested
that the effect of lethally irradiated cells
in reducing the number of viable cells
required to form a tumour graft is the
result of their stimulation of a local
clotting mechanism. We have found that
treatment with CY almost abolishes the
need for lethally irradiated cells, and
although we cannot rule out the possibility
that this treatment also enhances cell
retention at the injection site, we would
favour the hypothesis that CY acts by
depressing the nonspecific cellular defence
mechanisms, either in the lung or intra-
muscularly.
We acknowledge the support and help-
ful interest of Professor L. F. Lamerton
and Professor M. J. Peckham in this work,
and are grateful for the histopathological
advice of Dr R. L. Carter and Professor
S. L. Kauffman.
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